Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer

doi:10.4251/wjgo.v12.i7.782

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8720)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

400

WORD

182

HTML

3739

Figures (1-1)

303

Tables (1-2)

296

Sum=4920

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

369

Download

738

Sum=1107

Publishing Process of This Article

Item

Count

Browse

855

Download

1838

Sum=2693

Jul 15, 2020 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastrointest Oncol. Jul 15, 2020; 12(7): 782-790
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.782

Open in New Tab Full Size Figure Download Figure

Figure 1 Disease-free and overall survival rates in the conventional adjuvant chemotherapy group and hyperthermic intraperitoneal perfusion group. A: Disease-free survival rates; B: Overall survival rates. HIPEC: Hyperthermic intraperitoneal perfusion.

Citation: Xie TY, Wu D, Li S, Qiu ZY, Song QY, Guan D, Wang LP, Li XG, Duan F, Wang XX. Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer. World J Gastrointest Oncol 2020; 12(7): 782-790
URL: https://www.wjgnet.com/1948-5204/full/v12/i7/782.htm
DOI: https://dx.doi.org/10.4251/wjgo.v12.i7.782